If DesignWrite, the medical communications firm that has been ghostwriting articles on behalf of drug giant Wyeth, were an elementary school student, it would have a stack of papers heavy with gold stars.
Dr. Gloria Bachmann, the associate dean for women's health at the Robert Wood Johnson Medical School in New Brunswick, N.J., told the company it had written an "an A plus article" after it wrote a review article that Bachmann agreed to sign. The article appeared with hardly a word changed in The Journal of Reproductive Medicine.
This piece looks at the only majority-black nursing home in Illinois that earned the highest possible rating from Nursing Home Compare. The home is also noteworthy because it received that mark while having more than 85 percent of resident care paid for by Medicaid.
In December, Sen. Charles Grassley, R-Iowa, sent a letter to Mitchell A. Leon, the president of DesignWrite Inc., the company that has now become Exhibit A in the unfolding ghostwriting scandal that has medical journal editors everywhere combing through their submissions looking for fakes.
In a fascinating piece in the New York Times, Natasha Singer detailed how Dr. Gloria Bachmann leapt at the chance to sign her name to an article she had not written.
We continue our 5-part series on the high cost of health care in America.
We continue our 5-part series on the high cost of health care in America.
We continue our 5-part series on the high cost of health care in America.
We continue our 5-part series on the high cost of health care in America.
The doors are open at the Society of Professional Journalists, Northern California, 2009 Excellence in Journalism Competition.
From chapter president Ricardo Sandoval:
"These awards honor the journalists whose work best reflects the SPJ ideals of initiative, integrity, talent and compassion.
In addition to our regular categories, we are adding three new ones this year to reflect the ongoing evolution of the delivery of news and comment.
A look at the progress and potential pitfalls in California's $3 billion stem cell research program.
